News

Milestone Achieved: Leqembi® Sales Hit €200 Million Mark

Milestone Achieved: Leqembi® Sales Hit €200 Million Mark

Leqembi® Sales Milestone Achieved

BioArctic AB's (publ) partner, Eisai, has recently announced a significant milestone in their collaboration. Sales of Leqembi have impressively reached €200 million, representing a pivotal achievement for both companies. As a result of this accomplishment, BioArctic is set to receive a payment of €10 million, aligned with their licensing agreement.

Collaboration Between BioArctic and Eisai

The journey of Leqembi began with a fruitful partnership between BioArctic and Eisai. It all started with the innovative research and development led by Professor Lars Lannfelt, who played a crucial role in discovering the Arctic mutation linked to Alzheimer's disease. Eisai has taken charge of the clinical development, market approvals, and the commercialization of Lecanemab—another name for Leqembi—targeting Alzheimer's disease.

Clinical Development and Approvals

In the ever-evolving field of Alzheimer’s treatments, Lecanemab has gained substantial recognition. The positive approval trajectory has included numerous countries, enabling it to provide hope to those suffering from mild cognitive impairment and mild dementia caused by Alzheimer’s disease. The favorable outcomes from Eisai's global Clarity AD clinical trial were instrumental in achieving these regulatory endorsements, further validating Leqembi's effectiveness.

Future Prospects of Leqembi

Looking ahead, the future of Lecanemab appears promising. With a supplemental Biologics License Application recently approved by the FDA for less frequent intravenous dosing, combined with ongoing development of a subcutaneous auto-injection formulation, convenience for patients is set to increase significantly. The ongoing AHEAD 3-45 Phase 3 study is also shedding light on its effectiveness in individuals with early signs of Alzheimer's disease.

About BioArctic AB

Founded to pioneer innovative solutions in combating neurodegenerative diseases, BioArctic AB is at the forefront of medical research. The company has established itself as a leader in developing treatments like Leqembi®, which is hailed as one of the first drugs capable of slowing the progression of Alzheimer's disease. Apart from Leqembi, BioArctic's research efforts are directed at various neurological disorders, with multiple projects aiming at advancing therapeutic techniques and interventions.

Why This Milestone Matters

This sales milestone not only underscores the promising landscape of Alzheimer's treatments but also reflects the dedication and hard work shared between BioArctic and Eisai. As they continue to push the boundaries of medical science, the hope remains that effective solutions for Alzheimer's disease will be accessible to more patients around the world, empowering them and their families in the fight against this challenging condition.

Frequently Asked Questions

What is Leqembi® and how does it work?

Leqembi® (lecanemab) is an antibody designed to target and reduce amyloid-beta proteins associated with Alzheimer's disease, helping to slow the disease's progression.

What milestone has BioArctic recently achieved?

BioArctic has achieved a significant milestone as sales of Leqembi® have reached €200 million, resulting in a €10 million payment from Eisai.

Which markets have approved Lecanemab?

Lecanemab has been approved in the U.S., Japan, China, Great Britain, and several other regions for treating mild cognitive impairment due to Alzheimer's disease.

What are the future developments for Leqembi?

There are ongoing applications for less frequent dosing solutions and new formulations aimed at enhancing patient convenience.

Who can benefit from Leqembi?

Leqembi® is intended for individuals with mild cognitive impairment or mild dementia from Alzheimer’s disease, providing them with potential new treatment options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Telit Cinterion Tests Its Defense Connectivity Pitch

Updated Category News Views 107

Defense connectivity is a messy business, and Telit Cinterion is leaning straight into the mess at NATO Edge 2026 in Izmir, Turkey. From November 17 through 19, the company is using Booth L86 to show how several wireless links can live inside one mission-focused setup. That may sound like standard trade-show wallpaper, but the underlying problem is very real: military and...

Continue Reading
Hyster-Yale's $125 Million Convertible Debt Shuffle

Updated Category News Views 86

Forklifts do not make headlines often, but debt terms sure can. Hyster-Yale has proposed a $125 million private offering of convertible senior notes due November 15, 2031, with buyers able to take another $18.75 million if the initial purchasers exercise their option. For NYSE:HY holders, this is not a victory lap or a distress flare by itself. It is a refinancing...

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 45

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 121

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Sysco's Northern California Labor Deal Gets Bigger

Updated Category News Views 20

One hundred forty-four drivers may not rattle a giant food distributor by themselves, but labor agreements have a habit of growing legs. Sysco's Northern California and Nevada regional contract has added members from Teamsters Locals 386 and 431, bringing its coverage above 1,100 workers. For investors watching Sysco, this is less about one afternoon's headline and more...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 164

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 112

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 38

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 112

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 95

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading

Top 5 Most Recently Viewed Articles

Shell PLC's Strategic Share Repurchase Program Explained

Updated Category News Views 198

Understanding Shell PLC's Share Repurchase Strategy Shell plc has recently made headlines with its ongoing share buyback program. On a notable date, the company announced a significant purchase of its own shares intended for cancellation. This action is a part of its broader strategy to enhance shareholder value and optimize its capital structure. Details of the Share...

Continue Reading
Teck Resources Faces Maintenance Challenges at Chile Operations

Updated Category News Views 255

Maintenance Updates from Teck Resources Limited Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) has recently reported important updates regarding maintenance challenges at its operations in Chile. A mechanical issue has emerged at the Carmen de Andacollo (CdA) site, necessitating a temporary shutdown of the SAG mill. According to the latest information,...

Continue Reading
Neinor Homes Achieves FY24 Targets and New Shareholder Returns

Updated Category News Views 151

Neinor Homes Achieves Fiscal Targets for 2024 In a recent update, Neinor Homes reports successful fulfillment of its Adjusted Net Income target of €65 million for fiscal year 2024. The company, known for its prominence in residential property development, is now poised for continued growth. With the expected announcement of its fiscal results set for the latter part of...

Continue Reading
STG Logistics Staff Earn Supply Chain Accolades

Updated Category News Views 41

There's a fresh breeze running through the corridors of STG Logistics. Why? Because two of their own have snagged some serious recognition with the 2026 Women in Supply Chain Awards. This isn't just another blip on the corporate radar—it's a salute to the powerhouse of leadership and innovation nestled within the company's ranks. Geoff Anderman, the CEO himself, was...

Continue Reading
WISeKey International Holding Ltd Unveils AGM Agenda for Stakeholders

Updated Category News Views 284

WISeKey International Holding Ltd Unveils AGM Agenda for Stakeholders WISeKey International Holding Ltd, recognized for its significant contributions in the fields of cybersecurity and IoT, has announced the essential items for consideration by its shareholders at the upcoming Annual General Meeting (AGM). This important gathering, set to foster engagement between...

Continue Reading